| Literature DB >> 21407918 |
G Venkatasubramanian1, B H Yogananda, B N Gangadhar.
Abstract
A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response of the symptom clusters are discussed.Entities:
Keywords: NMS; dantrolene and bromocriptine; risperidone
Year: 2000 PMID： 21407918 PMCID： PMC2956992
Source DB: PubMed Journal: Indian J Psychiatry ISSN： 0019-5545 Impact factor: 1.759